Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism
- 30 November 2011
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (5), 963-971
- https://doi.org/10.1016/j.jhep.2011.02.011
Abstract
No abstract availableFunding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK080241)
- Harvard Clinical Nutrition Research Center (P30-DK040561)
- European Research Council Starting (TMIHCV 242699)
- BioMEMS Resource Center (P41EB-002503)
- Alexander Silberman Institute of Life Sciences
This publication has 43 references indexed in Scilit:
- Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and BioenergeticsPLoS Pathogens, 2010
- Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearanceProceedings of the National Academy of Sciences of the United States of America, 2009
- Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin ResistanceDiabetes, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateHepatology, 2008
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatology, 2008
- Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and SecretionJournal of Virology, 2008
- Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteinsProceedings of the National Academy of Sciences of the United States of America, 2007
- Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus ParticlesJournal of Virology, 2006
- Treatment of Hepatitis C InfectionGastroenterology Clinics of North America, 2006
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004